Status:
ACTIVE_NOT_RECRUITING
Long-term Effects of Breast Cancer Treatment
Lead Sponsor:
Norwegian Institute of Public Health
Collaborating Sponsors:
The Dam Foundation
Conditions:
Breast Cancer
Eligibility:
FEMALE
50-69 years
Brief Summary
The objective of this project is to generate evidence about quality of life related to side effects of treatment of women with screen-detected versus symptomatic breast cancer. The project will invest...
Detailed Description
The project will include a retrospective information which will be collected by using a self-administered questionnaire about the treatment women received and their quality of life at certain time poi...
Eligibility Criteria
Inclusion
- Study II
- Screened in BreastScreen Norway and diagnosed with breast cancer between 2006 and 2017
- Diagnosed with symptomatic breast cancer between 2006 and 2017 and never attended screening
- Screened in BreastScreen Norway and diagnosed with interval breast cancer between 2006 and 2017
- Screened in BreastScreen Norway and have never been diagnosed with breast cancer
Exclusion
- Death after recruitment
- Study III
- Inclusion Criteria:
- Screened in BreastScreen Norway and diagnosed with breast cancer between 2006 and 2017
- Screened in BreastScreen Norway and diagnosed with interval breast cancer between 2006 and 2017
- Diagnosed with symptomatic breast cancer between 2006 and 2017 and never attended screening
Key Trial Info
Start Date :
November 23 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2025
Estimated Enrollment :
4487 Patients enrolled
Trial Details
Trial ID
NCT03877029
Start Date
November 23 2019
End Date
May 1 2025
Last Update
October 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Registry of Norway
Oslo, Norway, 0304